ConductScience.org, home

Paper6537802

Increased tissue deposition and decreased excretion of platinum following administration of cisplatin to cisplatin-pretreated animals.

Litterst CL and 1 other. Cancer Chemother Pharmacol, 1984. Cited by 27 papers, by iCite.

Cite this record

ConductScience Library. Increased tissue deposition and decreased excretion of platinum following administration of cisplatin to cisplatin-pretreated animals. Papers, record 6537802. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6537802

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Increased tissue deposition and decreased excretion of platinum following administration of cisplatin to cisplatin-pretreated animals.
PubMed
Journal
Cancer Chemother Pharmacol
PubMed
Year
1984
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
27
iCite
Relative citation ratio, by iCite
1.62
iCite
Revised in PubMed
2026-10-10
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Litterst CLC L
2Schweitzer VGV G

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CisplatinMajor topic
PlatinumMajor topic
Animals
Female
Guinea Pigs
Kidney
Male
Rabbits
Tissue Distribution

Source PubMed

Download CSV of topics

References9

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16241789Cisplatinum: a review, with special reference to cellular and molecular interactions.Agents Actions1984https://conductscience.org/library/papers/6241789PubMed
24278921The preparation of red cell ghosts (membranes).Methods Enzymol1974https://conductscience.org/library/papers/4278921PubMed
3657154Acute renal failure after cis-dichlorodiammineplatinum(II) and gentamicin-cephalothin therapies.Cancer Treat Rep1978https://conductscience.org/library/papers/657154PubMed
46422414Ototoxic and nephrotoxic effects of combined treatment with cis-diamminedichloroplatinum and kanamycin in the guinea pig.Otolaryngol Head Neck Surg1984https://conductscience.org/library/papers/6422414PubMed
5966327Influence of certain metals on the level of metallothionein-like proteins in the liver and kidneys of rats.J Toxicol Environ Health1976https://conductscience.org/library/papers/966327PubMed
61277140Distribution and disposition of platinum following intravenous administration of cis-diamminedichloroplatinum(II) (NSC 119875) to dogs.Cancer Res1976https://conductscience.org/library/papers/1277140PubMed
7907657Analysis of platinum in biological materials by flameless atomic absorption spectrophotometry.Biochem Med1977https://conductscience.org/library/papers/907657PubMed
84831228Equine hepatic and renal metallothioneins. Purification, molecular weight, amino acid composition, and metal content.J Biol Chem1974https://conductscience.org/library/papers/4831228PubMed
94459127Studies on metal-binding proteins of low molecular weight from renal tissue of rabbits exposed to cadmium or mercury.Environ Physiol Biochem1974https://conductscience.org/library/papers/4459127PubMed

Download CSV of references

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.

PMIDTitleJournalYearIn PapersSource
20227292Shape changes induced by N-terminal platination of ubiquitin by cisplatin.J Am Soc Mass Spectrom2010https://conductscience.org/library/papers/20227292PubMed
8174197Factors affecting human autopsy kidney-cortex and kidney-medulla platinum concentrations after cisplatin administration.Cancer Chemother Pharmacol1994https://conductscience.org/library/papers/8174197PubMed
7706473Cisplatin-associated anemia: an erythropoietin deficiency syndrome.J Clin Invest1995https://conductscience.org/library/papers/7706473PubMed
7497604Long-term pharmacokinetic behavior of platinum after cisplatin administration.Cancer Chemother Pharmacol1995https://conductscience.org/library/papers/7497604PubMed
6428763Effects of the diuretics mannitol or acetazolamide on nephrotoxicity and physiological disposition of cisplatin in rats.Cancer Chemother Pharmacol1984https://conductscience.org/library/papers/6428763PubMed
6241789Cisplatinum: a review, with special reference to cellular and molecular interactions.Agents Actions1984https://conductscience.org/library/papers/6241789PubMed
3390078Correlations between cis-platinum dosage and toxicity in a guinea pig model.Arch Otorhinolaryngol1988https://conductscience.org/library/papers/3390078PubMed
2990752The effect of cisplatin on renal ATPase activity in vivo and in vitro.Cancer Chemother Pharmacol1985https://conductscience.org/library/papers/2990752PubMed
1931468Disposition and tumour concentrations of platinum in hypoalbuminaemic patients after treatment with cisplatin for cancer of the head and neck.Br J Clin Pharmacol1991https://conductscience.org/library/papers/1931468PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6537802

GET https://conductscience.org/api/papers/v1/6537802/authors